Company intelligence / Profile preview

Keata Pharma

Windsor, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Keata Pharma was a Canadian pharmaceutical development and manufacturing company based in Windsor, Ontario. Founded in 1991, the company specialized in the production of over-the-counter (OTC) and prescription medications, offering contract manufacturing services to global pharmaceutical partners. Keata Pharma was particularly recognized for its expertise in solid dosage forms and softgel encapsulation technology. In 2002, the company was acquired by Accucaps Industries Limited, which was subsequently acquired by Catalent in 2017. Today, the legacy of Keata Pharma continues through the Windsor facility, which remains a key site in Catalent's global manufacturing network.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Keata Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keata Pharma.

Explore the full profile